EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dietary Secoisolariciresinol Diglucoside Alleviates Polycystic Ovary Syndrome in Rats Through Inhibiting Inflammation and Modulating Gut/Vaginal Microbiota

Xiaoxia Zhang, Mei Liu, Shan Li, Yiwei Li, Junbai Ma, Yuanyuan Liu, Feng Zhang, Jiani Zhang, Ting Wang, Hao Wang

Endocrinology and Metabolism · 31.10.2026 · 41 (5) · 638-658

DOI: 10.3803/enm.2025.2660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.10.2026. Verfasst von Xiaoxia Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Butylene Glycols, Glucosides, Polycystic Ovary Syndrome, Inflammation. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Ningxia, China, Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome (PCOS) is an endocrine–metabolic disorder characterized by hyperandrogenism, anovulation, and polycystic ovaries, and it is frequently associated with low-grade inflammation and microbiota dysbiosis. Secoisolariciresinol diglucoside (SDG), a flax-derived polyphenol, exhibits estrogenic and anti-inflammatory properties. This study explored the therapeutic potential of dietary SDG in a rat model of PCOS.

Methods

Female Sprague-Dawley rats were divided into four groups: control, model, SDG-treated control, and SDG-treated model. After 3 weeks of PCOS modeling, dietary SDG was administered for 8 weeks. Samples were collected after the intervention for subsequent analyses.

Results

SDG improved estrous cyclicity, ovulation, ovarian morphology, and sex hormone balance. It reduced obesity, dyslipidemia, insulin resistance, and oxidative stress. Inflammation was alleviated through reductions in interleukin (IL)-1β, IL-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α, along with an elevation in IL-10. SDG increased splenic regulatory T cells and intestinal γδT cells while reducing ovarian and peritoneal macrophages. Gut microbiota composition was reshaped, with increased abundances of Bifidobacterium, Butyrivibrio, and Ruminiclostridium, and decreased abundances of Bacteroides and Parasutterella. Vaginal microbiota composition improved, as indicated by increased Lactobacillus and decreased Enterobacteriaceae. Plasma lipopolysaccharide levels decreased, whereas short-chain fatty acids increased. Metabolomic analysis highlighted alterations in histidine metabolism.

Conclusion

SDG ameliorates PCOS by suppressing inflammation and modulating gut and vaginal microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Butylene GlycolsGlucosidesPolycystic Ovary SyndromeInflammationGastrointestinal MicrobiomeVaginaAnimalsFemaleRats, Sprague-DawleyRatsDisease Models, Animal

Stichwörter der Autor:innen

Gut microbiotaInflammationPolycystic ovary syndromeSecoisolariciresinol diglucosideSex steroid hormonesVaginal microbiota

Substanzen

Butylene GlycolsGlucosidessecoisolariciresinol diglucoside

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, China.
  • School of Public Health, Ningxia Medical University, Yinchuan, China.
  • School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
  • Clinical Medical College, Ningxia Medical University, Yinchuan, China.
  • School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China. wangting950417@126.com.
  • College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, China. wanghaograduate@126.com.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Ningxia, China
  • Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China
  • Ningxia Natural Science Foundation
  • Program of Ningxia Science and Technology Leading Talent, China

Zitieren

APA

Zhang, X., Liu, M., Li, S., Li, Y., Ma, J., Liu, Y., Zhang, F., Zhang, J., Wang, T., & Wang, H. (2026). Dietary Secoisolariciresinol Diglucoside Alleviates Polycystic Ovary Syndrome in Rats Through Inhibiting Inflammation and Modulating Gut/Vaginal Microbiota. Endocrinology and Metabolism, 41(5), 638-658. https://doi.org/10.3803/enm.2025.2660

Vancouver

Zhang X, Liu M, Li S, Li Y, Ma J, Liu Y, et al. Dietary Secoisolariciresinol Diglucoside Alleviates Polycystic Ovary Syndrome in Rats Through Inhibiting Inflammation and Modulating Gut/Vaginal Microbiota. Endocrinology and Metabolism. 2026;41(5):638-658. doi:10.3803/enm.2025.2660

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoxia and Liu, Mei and Li, Shan and Li, Yiwei and Ma, Junbai and Liu, Yuanyuan and Zhang, Feng and Zhang, Jiani and Wang, Ting and Wang, Hao},
  title = {Dietary Secoisolariciresinol Diglucoside Alleviates Polycystic Ovary Syndrome in Rats Through Inhibiting Inflammation and Modulating Gut/Vaginal Microbiota},
  journal = {Endocrinology and Metabolism},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {638--658},
  doi = {10.3803/enm.2025.2660}
}
Kostenlos starten →